| Name | Opicinumab |
|---|
| Description | Opicinumab (BIIB033) is a monoclonal antibody against LINGO-1 and has potential application in acute optic neuritis and relapse multiple sclerosis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
LINGO-1[1] |
| References |
| No Any Chemical & Physical Properties |